|
 |
HEART TRANSPLANTATION
O Prada-Delgado, R Estvez-Loureiro... - ... Heart Transplantation, 2012 - ... 2012 Mar;31(3):332-3. Prevalence and prognostic value of cardiac allograft vasculopathy 1 year
after heart transplantation according to the ISHLT recommended nomenclature. Prada-Delgado
O, Estvez-Loureiro R, Paniagua-Martn MJ, Lpez-Sainz A, Crespo-Leiro MG. ...
S Dymarkowski... - Clinical Cardiac MRI, 2012 - Springer Heart failure (HF) may be the result of all forms of cardiac disease. Therefore, the development of accurate diagnostic tools for proper selection of therapeutic options is necessary to achieve good response rates in revascularization or resynchronization ... [CITATION] Prevalence and prognostic value of cardiac allograft vasculopathy 1 year after heart transplantation according to the ISHLT recommended nomenclature O Prada-Delgado, R Estvez-Loureiro... - The Journal of Heart and ..., 2012 - Elsevier
S Dymarkowski... - Clinical Cardiac MRI, 2012 - Springer Heart failure (HF) may be the result of all forms of cardiac disease. Therefore, the development of accurate diagnostic tools for proper selection of therapeutic options is necessary to achieve good response rates in revascularization or resynchronization ...
H Steen, E Hofmann... - Journal of Cardiovascular Magnetic ..., 2012 - Springer Background Non-invasive MRI tissue characterisation after HTX could potentially replace the hazardous myocardial biopsy for tissue staging and detection of transplant rejection. Recently, late gadolinium contrast enhanced cardiac MRI (LGE-CMR) showed infarct- ...
H Steen, E Hofmann... - Journal of Cardiovascular Magnetic ..., 2012 - Springer Background As recently shown, non-invasive late gadolinium contrast enhanced MRI (LGE-CMR) is able to detect myocardial infarction (MI) typical patterns in patients after heart transplant (HTX). Patho-physiologically, the underlying reason is an accelerated vascular ...
F Tona, M Perazzolo Marra, M Fedrigo... - Current Vascular ..., 2012 - Abstract: Heart transplantation (HTx) is the treatment of choice for patients with refractory end-stage heart diseases. Although the procedure is considered effective in extending and improving quality of life, the onset of cardiac allograft vasculopathy (CAV) continues to ... [CITATION] Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis RT Kamble, G Carrum, L Rice, J Mc Carthy... - Biology of Blood and ..., 2012 - Elsevier
|
|
|
